-
Placebos have been a part of medicine since ancient times, and remain both clinically relevant and philosophically interesting, according to a University of Chicago medical student whose research has shown that 45% of Chicago-area internists use placebos in their practice.
-
Lots has been written about physicians' unwillingness to report medical errors, but findings from the federal Agency for Healthcare Research and Quality (AHRQ) suggest it's not a lack of honesty and ethics at work it's a lack of confidence in current reporting systems.
-
Calls to legalize marijuana for medical use have come from an assortment of groups, but none with the status and influence of the American College of Physicians (ACP), the country's second-largest medical association, until now.
-
Clinical research teams and investigators may find that their traditional strategies for handling incidental findings during a trial are inadequate in this age of genetic research.
-
It's the ethical spectre that emerges with every advance in genetic testing. Should children be tested for gene mutations that predispose them to developing serious illnesses later in life?
-
If you serve on your hospital's ethics committee, does that make you a medical ethicist?
-
-
FDA recently announced these approvals: FDA approved Medtronic's Endeavor® Zotarolimus-Eluting Coronary Stent for use in treating patients with narrowed coronary arteries.
-
-
There has been recent emphasis in cardiology literature highlighting the importance of recognizing a new sub-specialty within the field, aimed at treating adult patients who have survived after having congenital heart disease repair.